About a half century before Sir Arthur Conan Doyle had the chance to chronicle the adventures of Sherlock Holmes, an unassuming anesthesiologist named John Snow informally introduced the wonders of deductive reasoning to the people of London. Snow, an English… Read More ›
Gilead’s New FDA Approved HIV Drug Improves Nothing, So Naturally It Costs A Lot
What do you suppose is the going rate for convenience? If you ask pharmaceutical giant and AIDS profiteer Gilead Sciences, the rate for an HIV+ person is somewhere around $29,000. The FDA announced yesterday, amid the media din accompanying the… Read More ›
A Cure or Some Cash?
There is always a point in researching any highly specialized subject when the documents you are reading stop being written in English. It doesn’t matter what the field is—biomedical research, law, literary criticism—there is a line in the sand that… Read More ›
Test and Treat…And Then What?
The only way we get through life with any semblance of sanity is through compartmentalization. Everyone of us has hundreds of different spheres and categories into which we make sense of our lives. Each weekday morning, most of us leave… Read More ›
The Color of Drug Money: Gilead Sciences and “Philanthropy”
By Drew Gibson Last night, while trudging through the endless cavalcade of reality shows on the TV guide, I came across a station that was playing The Gangs of New York. Naturally, I had to stop and watch it as… Read More ›
I am not a doctor. Nor am I a pharmacist or a nurse. Heck, I’m not even technically a social worker until (and if) I graduate from the University of Maryland-Baltimore SSW next year. However, I have been a citizen… Read More ›